Regulatory News
Thursday, December 29, 2016
U.S. FDA rejects Cempra's antibiotic for pneumonia
Dec 29 (Reuters) - Cempra Inc said the U.S. Food
and Drug Administration rejected its antibiotic for
community-acquired bacterial pneumonia (CABP), citing inadequate
data on the drug's impact on the...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment